Publications by authors named "Alvaro Hermida"

Claim this Profile
T
The organizational dimension in rare and complex diseases care management: an application of RarERN Path methodology in ataxias, dystonia and phenylketonuria.
Sara Cannizzo, Vinciane Quoidbach, Leopoldo Trieste, Monika Benson, Antonio Federico, Alvaro Hermida

BMC Health Serv Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis of bone mineral density in adults with phenylketonuria.
Júlio C Rocha, Álvaro Hermida, Cheryl J Jones, Yunchou Wu, Gillian E Clague

Orphanet J Rare Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic literature review of the somatic comorbidities experienced by adults with phenylketonuria.
Kaleigh B Whitehall, Sarah Rose, Gillian E Clague, Kirsten K Ahring, Deborah A Bilder, Álvaro Hermida

Orphanet J Rare Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nutrient Status and Intakes of Adults with Phenylketonuria.
Eva Venegas, Simone Langeveld, Kirsten Ahring, Rosa Benitez, An Desloovere, Alvaro Hermida

Nutrients· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from immediate- to extended-release cysteamine in patients with nephropathic cystinosis: from clinical trials to clinical practice.
Gema Ariceta, Fernando Santos, Andrés López Muñiz, Alvaro Hermida, Maria Luisa Matoses

Clin Kidney J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Consensus on the Long-Term Effectiveness of Medical Nutrition Therapy and Its Impact on the Outcomes of Adults with Phenylketonuria.
Júlio César Rocha, Kirsten K Ahring, Heather Bausell, Deborah A Bilder, Cary O Harding, Álvaro Hermida

Nutrients· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Spanish Fabry women study: a retrospective observational study describing the phenotype of females with GLA variants.
Rosario Sánchez, Tomás Ripoll-Vera, Manuel López-Mendoza, Joaquín de Juan-Ribera, Juan Ramón Gimeno, Álvaro Hermida

Orphanet J Rare Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of early treated adolescents and young adults with phenylketonuria: Development of international consensus recommendations using a modified Delphi approach.
Barbara K Burton, Álvaro Hermida, Amaya Bélanger-Quintana, Heather Bell, Kendra J Bjoraker

Mol Genet Metab· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a Novel Variant in Associated with a Severe Clinical Phenotype Expands the Clinical Spectrum of LTBL.
Sofia Barbosa-Gouveia, Emiliano González-Vioque, Álvaro Hermida, María Unceta Suarez, María Jesús Martínez-González

Genes (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbohydrate status in patients with phenylketonuria.
María L Couce, Paula Sánchez-Pintos, Isidro Vitoria, María-José De Castro, Luís Aldámiz-Echevarría, Alvaro Hermida

Orphanet J Rare Dis· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.
María L Couce, Isidro Vitoria, Luís Aldámiz-Echevarría, Ana Fernández-Marmiesse, Iria Roca, Alvaro Hermida

Orphanet J Rare Dis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis